News

WIRED have named 16 Trailblazer companies in Cambridge that are pushing boundaries and scaling up - including bit.bio. 

Authority Magazine interviewed bit.bio's SVP of tech ops and manufacturing Kathryn Golden to discover her path to leadership and w...

Our President and COO Kathryn Corzo talks with editor Brian Buntz from Drug Discovery & Development.

An article on synbio in the Summer 2023 issue of Science in Parliament magazine. Authored by our founder and CEO Mark Kotter.

Our CEO Mark Kotter talks to Drug Discovery World about different approaches to synthetic biology and its applications in drug dis...

This in depth feature covers bit.bio's breakthrough reprogramming approach and ability to manufacture human cells at industrial sc...

Kathryn Golden, SVP Technical Operations & Cell Manufacturing, discusses how our opti-ox technology lends itself to scale through ...

The piece covers bit.bio's breakthrough in industrialising the consistent manufacture of human cells and how this will transform h...